UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.358

Sortiert nach

A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists

Pharmacological reviews, 2013-04, Vol.65 (2), p.809

2013

Link zum Volltext

Verfügbarkeit prüfen

EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

European urology, 2013-07, Vol.64 (1), p.118-140

2013

Link zum Volltext

Verfügbarkeit prüfen

β3‐Adrenoceptors in the normal and diseased urinary bladder—What are the open questions?

British journal of pharmacology, 2019-07, Vol.176 (14), p.2525-2538

2019

Link zum Volltext

Verfügbarkeit prüfen

Where will the next generation of medical treatments for overactive bladder syndrome come from?

International journal of urology, 2020-04, Vol.27 (4), p.289-294

Michel, Martin C

2020

Link zum Volltext

Verfügbarkeit prüfen

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Neurourology and urodynamics, 2014-01, Vol.33 (1), p.17-30

2014

Link zum Volltext

Verfügbarkeit prüfen

The odd sibling: features of β3-adrenoceptor pharmacology

Molecular pharmacology, 2014-11, Vol.86 (5), p.479-484

2014

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Modulation of Urinary Bladder Function: Multiple Targets at Multiple Levels

Annual review of pharmacology and toxicology, 2015-01, Vol.55 (1), p.269-287

Michel, Martin C

2015

Link zum Volltext

Verfügbarkeit prüfen

How reliable are G-protein-coupled receptor antibodies?

Naunyn-Schmiedeberg's archives of pharmacology, 2009-04, Vol.379 (4), p.385-388

2009

Link zum Volltext

Verfügbarkeit prüfen

Progress in Functional Urology Reflected in Recent Papers in the Journal of Clinical Medicine

Journal of clinical medicine, 2023-07, Vol.12 (13), p.4482

Michel, Martin C

2023

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease

Pharmacology & therapeutics (Oxford), 2016-08, Vol.164, p.1-81

2016

Link zum Volltext

Verfügbarkeit prüfen

A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysis

European urology, 2012-11, Vol.62 (5), p.877-890

2012

Link zum Volltext

Verfügbarkeit prüfen

Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium

Naunyn-Schmiedeberg's archives of pharmacology, 2018-07, Vol.391 (7), p.675-694

2018

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans

Naunyn-Schmiedeberg's archives of pharmacology, 2015-08, Vol.388 (8), p.801-816

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome

Naunyn-Schmiedeberg's archives of pharmacology, 2013-03, Vol.386 (3), p.177-183

2013

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer

Naunyn-Schmiedeberg's archives of pharmacology, 2014-06, Vol.387 (6), p.505-521

2014

Link zum Volltext

Verfügbarkeit prüfen

The β3‐adrenoceptor agonist mirabegron increases human atrial force through β1‐adrenoceptors: an indirect mechanism?

British journal of pharmacology, 2017-08, Vol.174 (16), p.2706-2715

2017

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of urinary bladder hypertrophy in experimental diabetes: Part 2. Comparison of animal models and functional consequences

Neurourology and urodynamics, 2018-11, Vol.37 (8), p.2346-2360

2018

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the β3-Adrenoceptor Agonist Solabegron for Overactive Bladder

European urology, 2012-11, Vol.62 (5), p.834-840

2012

Link zum Volltext

Verfügbarkeit prüfen

Effects of Nifedipine on Renal and Cardiovascular Responses to Neuropeptide Y in Anesthetized Rats

Molecules (Basel, Switzerland), 2021-07, Vol.26 (15), p.4460

2021

Link zum Volltext

Verfügbarkeit prüfen

Adrenoceptors—New roles for old players

British journal of pharmacology, 2019-07, Vol.176 (14), p.2339-2342

2019

Link zum Volltext

Verfügbarkeit prüfen

Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes?

Biomolecules (Basel, Switzerland), 2023-12, Vol.13 (12), p.1714

2023

Link zum Volltext

Verfügbarkeit prüfen

Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big Data

Frontiers in pharmacology, 2016-12, Vol.7, p.461-461

2016

Link zum Volltext

Verfügbarkeit prüfen

A 25-Year Journey as Author and Associate Editor of Pharmacological Reviews -Editorial

Pharmacological reviews, 2024-02, Vol.76 (2), p.196

Michel, Martin C

2024

Link zum Volltext

Verfügbarkeit prüfen

Good Research Practice in Non-Clinical Pharmacology and Biomedicine

1st ed. 2020., 2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: G Protein-Coupled Receptor Kinases (GRKs) and β-Arrestins: New Insights Into Disease Regulators

Frontiers in pharmacology, 2020-01, Vol.10, p.1654-1654

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.358

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.395)
Mit Volltextzugriff
(3.835)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.132)
Life Sciences & Biomedicine
(1.730)
Humans
(1.360)
Male
(817)
Female
(726)
Biological And Medical Sciences
(654)
Animals
(527)
Medical Sciences
(513)
Middle Aged
(445)
Adult
(443)
Life Sciences
(348)
Aged
(331)
Physical Sciences
(306)
Pharmacology & Pharmacy
(288)
Physics
(196)
Fundamental And Applied Biological Sciences. Psychology
(188)
Surgery
(171)
Pharmacology. Drug Treatments
(164)
Treatment Outcome
(162)
Adolescent
(158)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists

EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

β3‐Adrenoceptors in the normal and diseased urinary bladder—What are the open questions?

Where will the next generation of medical treatments for overactive bladder syndrome come from?

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

The odd sibling: features of β3-adrenoceptor pharmacology

Therapeutic Modulation of Urinary Bladder Function: Multiple Targets at Multiple Levels

How reliable are G-protein-coupled receptor antibodies?

Progress in Functional Urology Reflected in Recent Papers in the Journal of Clinical Medicine

Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease

A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysis

Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium

A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans

Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome

A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer

The β3‐adrenoceptor agonist mirabegron increases human atrial force through β1‐adrenoceptors: an indirect mechanism?

A systematic review of urinary bladder hypertrophy in experimental diabetes: Part 2. Comparison of animal models and functional consequences

A Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the β3-Adrenoceptor Agonist Solabegron for Overactive Bladder

Effects of Nifedipine on Renal and Cardiovascular Responses to Neuropeptide Y in Anesthetized Rats

Adrenoceptors—New roles for old players

Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes?

Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big Data

A 25-Year Journey as Author and Associate Editor of Pharmacological Reviews -Editorial

Good Research Practice in Non-Clinical Pharmacology and Biomedicine

Editorial: G Protein-Coupled Receptor Kinases (GRKs) and β-Arrestins: New Insights Into Disease Regulators

Suchergebnisse filtern